Study of potential vaccine candidates from Leptospira interrogans serovar Copenhageni. / Estudo de potencias antígenos vacinais de Leptospira interrogans sorovar Copenhageni.

AUTOR(ES)
DATA DE PUBLICAÇÃO

2009

RESUMO

Preventive measures as vaccines are the best strategies to combat leptospirosis. Seven potential vaccine candidates from L. iInterrogans serovar Copenhageni were studied: LipL32, LipL23 and LipL22 (lipoproteins), SphH e Sph4 (hemolysins), AnkB (ankyrin domain) and OmpA76 (OmpA domain). The genes were amplified, cloned and the proteins expressed in E. Coli e Salmonella enteric for challenge assays. In the first assay, hamsters were immunized with the recombinant salmonella to express OmpA76 in vivo, and challenged with serovar Pomona. The survival was 30% of the recombinant salmonella group, 100% of the commercial vaccine and 10% of the control groups. In the second assay, hamsters were immunized with a pool of the purified proteins and challenged with serovar Copenhageni. The survival was 30% of the group pool of proteins, 90% of the commercial vaccine, 100% of the bacterin and 0% of the PBS group. LipL32, OmpA76, LipL23 and LipL22 reacted with hamsters infected sera. Leptospiral extracts were recognized by specific sera against LipL32, OmpA76 and LipL23.

ASSUNTO(S)

vacinas salmonella antigens of bacteria vaccines biotecnologia leptospirose leptospirose animal biotechnology antígenos de bactérias salmonella leptospirosis leptospirosis feed

ACESSO AO ARTIGO

Documentos Relacionados